iifl-logo

Senores Pharmaceuticals Ltd Share Price Live

719.15
(2.14%)
Sep 5, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open704
  • Day's High732
  • 52 Wk High737.85
  • Prev. Close704.05
  • Day's Low700.15
  • 52 Wk Low 435.25
  • Turnover (lac)1,698.33
  • P/E0
  • Face Value10
  • Book Value154.31
  • EPS1.32
  • Mkt. Cap (Cr.)3,311.94
  • Div. Yield0
View All Historical Data

No Record Found

Loading...

Senores Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

704

Prev. Close

704.05

Turnover(Lac.)

1,698.33

Day's High

732

Day's Low

700.15

52 Week's High

737.85

52 Week's Low

435.25

Book Value

154.31

Face Value

10

Mkt Cap (₹ Cr.)

3,311.94

P/E

0

EPS

1.32

Divi. Yield

0

Senores Pharmaceuticals Ltd Corporate Action

17 Jul 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Senores Pharmaceuticals Ltd NEWS AND UPDATE

Dr. Reddy’s Laboratories Sells 14 ANDAs to Senores Pharma

Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.

5 Mar 2025|11:05 AM
Read More
Senores Stock Dips from High, Remains Above IPO Price

Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.

30 Dec 2024|04:08 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Senores Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

05 Sep, 2025|11:17 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 6.31%

Foreign: 6.31%

Indian: 39.46%

Non-Promoter- 13.17%

Institutions: 13.17%

Non-Institutions: 41.04%

Custodian: 0.00%

Share Price

Senores Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023Mar-2022

Equity Capital

46.05

30.51

9.82

8.74

Preference Capital

0

0

0

0

Reserves

661.92

137.61

29.11

24.95

Net Worth

707.97

168.12

38.93

33.69

Minority Interest

View Balance Sheet

No Record Found

No Record Found

No Record Found

Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022

Gross Sales

377.98

214.52

35.34

14.17

Excise Duty

0

0

0

0

Net Sales

377.98

214.52

35.34

14.17

Other Operating Income

20.27

0

0

0

Other Income

19.26

2.82

3.68

0.46

Senores Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,582.3

76.223,79,658.77753.531.015,566.68101.44

Divis Laboratories Ltd

DIVISLAB

6,133.5

69.731,62,886.215570.492,357561.08

Cipla Ltd

CIPLA

1,577.8

24.671,27,435.321,303.131.014,501.66397.38

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,599.3

61.231,21,713.055510.172,567224.34

Mankind Pharma Ltd

MANKIND

2,568.9

58.531,05,917.96412.7602,541.36354.69

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Senores Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Managing Director

SWAPNIL JATINBHAI SHAH

Chairman (Non-Executive)

Sanjay Majmudar

Non Executive Director

Hemanshu Nitinchandra Pandya

Independent Director

Jitendra Babulal Sanghvi

Whole Time Director & Chief Operating Officer

Chetan Bipinchandra Shah

Whole Time Director & Chief Financial Officer

Deval Rajnikant Shah

Non Executive Director

Ashokkumar Vijaysinh Barot

Non Executive Director

ARPIT DEEPAKKUMAR SHAH

Independent Director

Naresh Bansilal Shah

Independent Director

Manjula Devi Shroff

Independent Director

Kalpit Rajesh Gandhi

Independent Director

Udayan Choksi

Company Sec. & Compli. Officer

Nidhi Dilipbhai Kapadia

Registered Office

#.1101-1103 11th Flr South Twr,

Ambali Bopal Road,

Gujarat - 380054

Tel: +91-79-2999 9857

Website: http://www.senorespharma.com

Email: cs@senorespharma.com

Registrar Office

C-101 247 Park,

L B S Marg, Vikhroli West,

Mumbai-400083

Tel: 91-22-49186000

Website: www.linkintime.co.in

Email: paytm.ipo@linkintime.co.in

Summary

Senores Pharmaceuticals Limited was originally incorporated as Senores Pharmaceuticals Private Limited through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Compan...
Read More

Company FAQs

What is the Senores Pharmaceuticals Ltd share price today?

The Senores Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹719.15 today.

What is the Market Cap of Senores Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Senores Pharmaceuticals Ltd is ₹3311.94 Cr. as of 05 Sep ‘25

What is the PE and PB ratio of Senores Pharmaceuticals Ltd?

The PE and PB ratios of Senores Pharmaceuticals Ltd is 0 and 4.58 as of 05 Sep ‘25

What is the 52 Week High and Low of Senores Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Senores Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Senores Pharmaceuticals Ltd is ₹435.25 and ₹737.85 as of 05 Sep ‘25

What is the CAGR of Senores Pharmaceuticals Ltd?

Senores Pharmaceuticals Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 26.39%, 6 Month at 25.16%, 3 Month at 36.60% and 1 Month at 1.08%.

What is the shareholding pattern of Senores Pharmaceuticals Ltd?

The shareholding pattern of Senores Pharmaceuticals Ltd is as follows:
Promoters - 45.78 %
Institutions - 13.17 %
Public - 41.04 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.